Emergen Research latest document, titled ‘Global non-invasive prenatal testing Market - Forecast to 2027,’ is one of the most sought-after market reports involving an in-depth analysis of the global non-invasive prenatal testing market. The report’s authors have offered necessary details on the latest non-invasive prenatal testing market trends and the crucial parameters impacting both short-term and long-term market growth. Its panoramic view of the non-invasive prenatal testing industry entails useful insights into the estimated non-invasive prenatal testing market size, revenue share, and sales distribution networks.Our experienced market research team has provided updated information on the ongoing COVID-19 pandemic and its adverse economic impact in the latter segment of the report.  The coronavirus outbreak has led to drastic changes in the current non-invasive prenatal testing business landscape, limiting the growth opportunities for various manufacturers and buyers for the next few years

Its panoramic view of the non-invasive prenatal testing industry entails useful insights into the estimated non-invasive prenatal testing market size, revenue share, and sales distribution network such helpful market insights are bound to help readers outline this industry’s key outcomes in the near future. Those are further intended to assist businesses involved in this sector in sound decision-making and formulating lucrative business plans. The primary addressees of this report include some of the globally renowned venture capitalists

Key participants include Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others.

Get a sample of the report : https://www.emergenresearch.com/request-sample/16

With the increasing occurrence of pregnancy and complications, non-invasive prenatal testing is expected to become a routine procedure in the future, replacing other, riskier screening procedures. NIPT has more than 99% identification sensitivity and shows screening in less time than other prenatal screening forms. So few players provide non-invasive pregnancy monitoring. The high cost of research and the interim diagnostic method restrains business expansion.

Annually, an average USD 4,879.0 is expended on child healthcare in the U.S., which is expected to benefit the non-invasive pregnancy testing sector in North America, according to work conducted by the Health Expense Institute. Due to the increasing focus on minimally invasive diagnostic procedures and preference for early detection of illness, the recognition among citizens and expanding healthcare services, Asia Pacific is projected to grow significantly in the global market for non-invasive prenatal research.

Further key findings from the report suggest

Based on the method, ultrasound detection generated a revenue of USD 0.86 billion in 2019 and believed to rise with a CAGR of 14.0% in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb.

The hospital segment expected to grow with a CAGR of 14.1% in the forecasted period due to the growing introduction of non-invasive prenatal testing coupled with rapid technological developments and groundbreaking acceptance strategies.

The trisomy application is the major contributor to the Non-Invasive Prenatal Testing Market. The trisomy application of the North America region is the major shareholder of the market and held around 45.1% of the market in the year 2019, owing to the high incidence of genetic disorders correlated with trisomy’s, such as Patau syndrome, Down syndrome, and Edward syndrome.

North America dominated the market for Non-Invasive Prenatal Testing in 2019 due to the availability of technologically advanced healthcare research system, the region's production of WGS. The North America region held approximately 48.8% of the market, followed by Europe, which contains around 25.4% market in the year 2019.

Request a discount on the report : https://www.emergenresearch.com/request-discount/16

 Key Questions Answered in the Report:

What is the growth rate of the non-invasive prenatal testing market? What is the anticipated market valuation of non-invasive prenatal testing industry by 2027?

What are the key growth driving and restraining factors of the non-invasive prenatal testing market?

Who are the prominent players operating in the market? What are the key strategies adopted by these companies?

What are the key opportunities and growth prospects of the non-invasive prenatal testing industry over the forecast period?

Which region is expected to show significant growth in the coming years?

For the purpose of this report, Emergen Research has segmented into the global Non-Invasive Prenatal Testing market based on the method, end-use, application, and region:

Method Outlook (Revenue, USD Billion; 2017-2027)

• Ultrasound Detection
• Biochemical Screening Tests
• Cell-free DNA in Maternal Plasma Tests
• Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)

• Diagnostic Laboratories
• Hospitals
• Research Centers
• Clinics

Application Outlook (Revenue, USD Billion; 2017-2027)

• Trisomy
• Microdeletion Syndrome
• Others

Finally, non-invasive prenatal testing Market is a valuable source of guidance for individuals and companies.

Regional Segmentation;

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Read More: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

Related reports:

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs